MEK inhibitors in oncology: a patent review (2015-Present)
Year: 2017
Type: review
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: MEK inhibitors, RAS/MAPK pathway, PI3K/AKT/mTOR pathway, metastatic melanoma, BRAF mutation, KRAS mutation, multikinase inhibitor, acquired drug resistance, relapsed/refractory multiple myeloma, colorectal adenocarcinoma, pancreatic ductal adenocarcinoma, precision oncology, pharmaceutical patents
Open Access status: closed
Funder: University Grants Commission
OpenAlex ID: W2622197960
